Livongo Stock

livongo.comHealthcare / Digital HealthFounded: 2007Funding to Date: $237.65MM

Livongo (formerly Retrofit) is digital healthcare company offering mobile, online and personalized, real-time support for people at risk for or living with chronic conditions.

Register To Buy and Sell Shares

For more details on financing and valuation for Livongo, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Livongo’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Livongo.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Glen Tullman
Founder & Executive Chairman
Dave Engberg
Chief Technology Officer
Amar Kendale
Chief Product Officer
Zane Burke
Chief Executive Officer
Lee Shapiro
Chief Financial Officer
Arnnon Geshuri
Chief People Officer
Courtnee Westendorf
Chief Marketing Officer
Jennifer Schneider
Jim Pursley
Chief Commercial Officer
Dr. Bimal Shah
Chief Medical Officer
Anmol Madan
Chief Data Scientist

Board Members

Zane Burke
Philip D. Green
PDG Consulting, LLC
Chris Bischoff
Hemant Taneja
General Catalyst
Karen L. Daniel
Black & Veatch Corporation
Sandra Fenwick
Boston Children’s Hospital
Glen Tullman

News Highlights

A top investor at Alphabet's growth fund says the soaring cost of chronic care is fueling a new crop of startups like Livongo and shares where he wants to place his bets in 2021
Livongo's success and the sky-high cost of chronic care are fueling the next breed of healthcare startups.
Teladoc Health CEO talks Livongo integration, importance of behavioral science
Teladoc Health CEO Jason Gorevic said the virtual care provider shares the same values as Livongo, the diabetes management it recently acquired.
10 healthcare startups that could be M&A targets after Teladoc's record-breaking $18.5 billion deal for Livongo
Amwell is filing to go public, and more will likely follow suit in light of Teladoc's blockbuster Livongo acquisition.
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.